Status:
RECRUITING
Exploratory Clinical Study on Fasting in Psoriasis and Psoriatic Arthritis (RiseFast)
Lead Sponsor:
Charite University, Berlin, Germany
Collaborating Sponsors:
Max Delbrück Center for Molecular Medicine (MDC), Berlin
Conditions:
Psoriasis Arthritis
Psoriasis (PsO)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The RiseFast pilot study will investigate the clinical, metabolic and immunological effects of fasting and plant-based diet (PBD) on patients with psoriasis (PsO) and psoriatic arthritis (PsA) on thei...
Detailed Description
Psoriatic disease, encompassing psoriasis (PsO) and psoriatic arthritis (PsA) is a chronic inflammatory condition influenced by genetic, immune, and environmental factors, particularly diet and gut mi...
Eligibility Criteria
Inclusion
- Active plaque psoriasis (PASI ≥3) or Psoriatic Arthritis fulfilling the Classification Criteria for Psoriatic Arthritis (CASPAR) and not meeting MDA criteria
- on stable baseline psoriatic treatment for 12 weeks before enrollment
- ≥ 18 years old
Exclusion
- Pregnancy or breastfeeding
- underweight (BMI ≤18,5)
- eating disorder in the last 5 years
- severe internal diseases (e.g. renal insufficiency with creatinine \> 2mg/dl)
- current practice of vegan diet or fasting within the past 6 months
- use of antibiotics within the past 3 months
Key Trial Info
Start Date :
April 30 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06905028
Start Date
April 30 2025
End Date
June 1 2026
Last Update
April 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité - Universitätsmedizin Berlin, Psoriasis-Forschungs- und BehandlungsCentrum
Berlin, State of Berlin, Germany, 10117